Aldehydes are a class of chemicals made in our own bodies in small quantities but increasingly found everywhere in our environment. Exposure to these chemicals has previously been linked with cancer, but the reasons for the link remain unclear.
Researchers, led by Professor Ashok Venkitaraman from the University of Cambridge in the UK, used genetically-engineered human cells and cells from patients bearing a faulty copy of the breast cancer gene BRCA2 to identify the mechanism by which exposure to aldehydes could promote cancer.
However, researchers found that aldehyde exposure breaks down this defence mechanisms even in normal healthy cells, but people who have inherited a faulty copy of BRCA2 are particularly sensitive to such damage.
Everyone is born with two copies of most genes. People who inherit a single faulty copy of the BRCA2 gene are susceptible to cancer.
The reason behind this is not fully understood, because their cells should be able to repair DNA using the lower - but still adequate - levels of BRCA2 protein made from the remaining, intact copy of the gene.
In people who inherit one faulty copy of the BRCA2 gene, this effect pushes down BRCA2 protein levels below the amount required for adequate DNA repair, breaking down the normal mechanisms that prevent mutations, which could promote cancer formation.
"Our study shows how chemicals to which we are increasingly exposed in our day-to-day lives may increase the risk of diseases like cancer," said Venkitaraman.
"It also helps to explain why the faulty genes could make some people particularly sensitive to the cancer-causing effects of these chemicals," he added.
One common potential source of aldehydes is alcohol: our body converts the alcohol that we drink into acetaldehyde, one such chemical.
Ordinarily, this is broken down by a natural enzyme known as acetaldehyde dehydrogenase, but over 500 million people mainly from countries such as Japan, China and Korea inherit a faulty gene, ALDH2, that inactivates this enzyme.
This new research shows that aldehyde accumulation in such people could trigger cancer susceptibility by degrading BRCA2, compromising DNA repair, whether or not they inherit a faulty copy of BRCA2.
An estimated 30-60 per cent of people from Japan, Korea and China carry the faulty ALDH2 and may therefore be at risk from cancer through this new mechanism.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
